Hispidulin suppresses osteosarcoma by directly targeting FABP4 to disrupt lipid metabolism and inhibit the PI3K/AKT pathway

Xuhui Yuan(Nanchang University), Lingxiao Zhu(C3J Therapeutics (United States))
Journal of Translational Medicine
October 7, 2025
Cited by 2


Related Papers